Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | Liverpool School of Tropical Medicine |
| Country | United Kingdom |
| Start Date | Sep 30, 2024 |
| End Date | Sep 29, 2028 |
| Duration | 1,460 days |
| Number of Grantees | 1 |
| Roles | Supervisor |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2927492 |
Malaria is a major cause of mortality and morbidity in Sub-Saharan Africa (SSA) and one of the biggest impediments to the economic development. The major method for controlling these malaria-transmitting mosquitoes is through the use of chemical insecticides but resistance has emerged and is a major threat to the recent reductions in both deaths and malaria infections.
The PhD student will work within large vector control trials in East Africa. There is a high degree of flexibility within the project and the student may choose to:- apply genomic sequencing approaches to investigate the key genetic drivers of insecticide resistance use CRISPR/Cas to functionally characterise resistance candidates
develop insecticide resistance models to quantify the impact of resistance on intervention efficacy on epidemiological indicators. Work will be conducted at LSTM with an opportunity to conduct part of the research with partners in Kenya.
Liverpool School of Tropical Medicine
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant